Radiofrequency Ablation: Effect of Pharmacologic Modulation of Hepatic and Renal Blood Flow on Coagulation Diameter in a VX2 Tumor Model

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 3, 2004, Pages 269-274

  Horkan, Clare ^a   Ahmed, Muneeb ^a   Liu, Zhengjun ^a   Gazelle, G Scott ^b   Solazzo, Stephanie A ^a   Kruskal, Jonathan B ^a   Goldberg, S Nahum ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARSENIC TRIOXIDE; DRUG; HALOTHANE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CATHETER ABLATION; COAGULATION DIAMETER; COAGULATION NECROSIS; CONTROLLED STUDY; DRUG EFFECT; KIDNEY BLOOD FLOW; KIDNEY TUMOR; LASER DOPPLER FLOWMETRY; LIVER BLOOD FLOW; LIVER TUMOR; MODULATION; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; TUMOR BLOOD FLOW; TUMOR MODEL; TUMOR NECROSIS; VX2 TUMOR MODEL;

EID: 1542373626     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000109396.74740.C4     Document Type: Article

References (32)

1. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities-part II. J Vasc Interv Radiol 2001; 12:1135-1148.
2. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227:559-565.
3. Rossi S, Garbagnati F, De Francesco I, et al. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori 1999; 85:128-132.
4. Schultze D, Morris CS, Bhave AD, Worgan BA, Najarian KE. Radiofrequency ablation of renal transitional cell carcinoma with protective cold saline infusion. J Vasc Interv Radiol 2003; 14:489-492.
5. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9:101-111.
6. Scott DJ, Fleming JB, Watumull LM, Lindberg G, Tesfay ST, Jones DB. The effect of hepatic inflow occlusion on laparoscopic radiofrequency ablation using simulated tumors. Surg Endosc 2002; 16:1286-1291.
7. Yamakado K, Nakatsuka A, Ohmori S, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002; 13:1225-1232.
8. Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. AJR Am J Roentgenol 2002; 178:47-51.
9. Goldberg SN, Hahn PF, Halpern EF, Fogle RM, Gazelle GS. Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998; 209:761-767.
10. Grundmann U, Zissis A, Bauer C, Bauer M. In vivo effects of halothane, enflurane, and isoflurane on hepatic sinusoidal microcirculation. Acta Anaesthesiol Scand 1997; 41:760-765.
11. Griffin RJ, Lee SH, Rood KL, et al. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors. Neoplasia 2000; 2:555-560.
12. Lew YS, Brown SL, Griffin RJ, Song CW, Kim JH. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown. Cancer Res 1999; 59:6033-6037.
13. Ackerman NB, Jacobs R, Bloom ND, Poon TT. Increased capillary flow in intrahepatic tumors due to alpha-adrenergic effects of catecholamines. Cancer 1988; 61:1550-1554.
14. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev 1994; 13:209-222.
15. Ahmed M, Liu Z, Afzal KS, et al. Radiofrequency tumor ablation: effect of surrounding tissue composition on induced coagulation. Radiology (in press).
16. Boehm T, Malich A, Goldberg SN, et al. Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model. Radiology 2002; 222:805-813.
17. Goldberg SN, Walovitch RC, Straub JA, Shore MT, Gazelle GS. Radio-frequency-induced coagulation necrosis in rabbits: immediate detection at US with a synthetic microsphere contrast agent. Radiology 1999; 213:438-444.
18. Soignet SL, Frankel SR, Douer D, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001;19:3852-3860.
19. Chavez-Cartaya RE, Ramirez-Romero P, Calne RY, Jamieson NV. Laser-Doppler flowmetry in the study of in vivo liver ischemia and reperfusion in the rat. J Surg Res 1994; 56:473-477.
20. Jimbo T, Akimoto T, Tohgo A. Systemic administration of a synthetic lipid A derivative, DT-5461a, reduces tumor blood flow through endogenous TNF production in hepatic cancer model of VX2 carcinoma in rabbits. Anticancer Res 1996; 16:359-364.
21. Yanagibashi K, Imamura M, Tobe T. Evaluation of microcirculation in the tumor-bearing liver of rabbits by laser-Doppler flowmetry. Nippon Geka Hokan 1992; 61:3-18.
22. Liszczak TM, Hedley-Whyte ET, Adams JF, et al. Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol 1984; 65:150-157.
23. Goldberg SN, Kamel IR, Reynolds KF, Stuart KE, Raptopoulos VD, Kruskal JB. Radiofrequency tumor ablation: Increased coagulation of liver tumors with adjuvant liposomal doxorubicin monitored with 3D CT reconstruction techniques. Radiology 2001; 201(suppl): 627.
24. Kim HC, Kim TK, Sung KB, et al. CT during hepatic arteriography and portography: an illustrative review. Radiographics 2002; 22:1041-1051.
25. Bosniak MA, Ambos MA, Madayag MA, Lefleur RS, Casarella WJ. Epinephrine-enhanced renal angiography in renal mass lesions: is it worth performing? AJR Am J Roentgenol 1977; 129:647-652.
26. Elliott RH, Strunin L. Hepatotoxicity of volatile anaesthetics. Br J Anaesth 1993; 70:339-348.
27. Beaune PH, Lecoeur S. Immunotoxicology of the liver: adverse reactions to drugs. J Hepatol 1997; 26(suppl 2):37-42.
28. Small EJ, Halabi S, Dalbagni G, et al. Overview of bladder cancer trials in the Cancer and Leukemia Group B. Cancer 2003; 97(suppl 8):2090-2098.
29. Du YH, Ho PC. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines. Cancer Chemother Pharmacol 2001; 47:481-490.
30. Maeda H, Hori S, Nishitoh H, et al. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 2001; 61:5432-5440.
31. Kang SH, Song JH, Kang HK, et al. Arsenic trioxide-induced apoptosis is independent of stress-responsive signaling pathways but sensitive to inhibition of inducible nitric oxide synthase in HepG2 cells. Exp Mol Med 2003; 35:83-90.
32. Li X, Ding X, Adrian TE. Arsenic trioxide inhibits proliferation and induces apoptosis in pancreatic cancer cells. Anticancer Res 2002; 22:2205-2213.